In vitro cytotoxicity of paclitaxel-transferrin conjugate on H69 cells

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1381-1383

  Bicamumpaka, Cyrille ^a   Pagé, Michel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b BCM Developpement Inc   (Canada)

Author keywords

H69; Paclitaxel; Paclitaxel transferrin conjugate; Small cell carcinoma of the lung

Indexed keywords

TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; GROWTH REGULATION; HUMAN; HUMAN CELL; IRON TRANSPORT; LUNG SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 0031715649     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1381     Document Type: Article

References (16)

1. Wani MC, Taylor HL, Monroe EF, Wall ME, Coggon NP and McPhail AT: Plant antitumor agents. VI. The isolation and structure of paclitaxel a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Denis JN, Greene AE, Guerite-Voegelin F, Mangatal L and Poitier P: A highly efficient, practical approach to natural paclitaxel. J Am Chem Soc 110: 5917-5919, 1988.
3. Suffness M: Paclitaxel: from discovery to therapeutic use. In: Annual Reports in Medicinal Chemistry. Vol. 28. Bristol JA (ed). Michigan, 1993.
4. Trimble EL, Arbuck SG and McGuire W: Options for primary chemotherapy of epithelial ovarian cancer. Taxanes Gynecol Oncol 55: 114-121, 1994.
5. Rowinsky EK, Lorraine A, Cazenave Ross C, Donehower RC: Paclitaxel: a novel investigational antimicrotubule asent. J Natl Cancer Inst 82: 1247-1259, 1990.
6. Kingston DC: The chemistry of paclitaxel. Pharmacol Ther 52: 1-34, 1991.
7. Borman S: Total synthesis of anticancer agent paclitaxel was achieved by two different routes. C&EN 72: 32-34, 1994.
8. Swindell CS: Taxane diterpene synthesis strategies. A review. Org Prep Proced Int 23: 465-543, 1991.
9. Mellado W, Magri NF, Kingston DG, Garcia-Arenas R, Orr GA and Horwitz SB: Preparation and biological activity of taxol acetates. Biochem Biophys Res Commun 105: 1082-1089, 1984.
10. Kingston DG, Samaranayake G and Ivey CA: The chemistry of paclitaxel, a clinically useful anticancer agent. J Nat Prod 53: 1-13, 1990.
11. Lemieux P: Ciblage de conjugués Daunorubicine-Transferrine contre les tumeurs péritonéales, 1989. Ciblage de conjugués daunorubinine-transferrine contre les tumeurs du péritoine, p. 55 Master degree thesis. Laval University, Quebec city, 1981.
12. Carney DN, Bunn PA and Gazdar AF: Selective growth in a serum-free hormone supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci USA 78: 3185-3189, 1981.
13. Bicamumpaka C and Pagé M: Development of a fluorescence polarization immunoassay (FPIA) for the quantitative determination of paclitaxel. J Immunol Methods (In press).
14. Deutsch HM, Glinski JA, Hernandez M, Haugwitz RD, Narayan VL, Suffness M and Zalkow LH: Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. J Med Chem 32: 788-792, 1989.
15. Thibault D and Pagé M: Coupling daunorubicin to monoclonal antialpha-fetoprotein with a new activated derivative. Int J Immunopharmacol 12: 503-507, 1990.
16. Lamontagne P, Maion G and Pagé M: Cytotoxicity testing using a soluble tetrazolium formazan derivative. Cell Pharmacol 1: 171-174, 1994.